Efficacy and Safety of Brexucabtagene Autoleucel for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Patients Aged 60 and Above
Ibrahim N. Muhsen, Kristen M. O'Dwyer(University of Rochester), Wendy Stock(University of Chicago), Joshua Sasine(Cedars-Sinai Medical Center), Simone E. Dekker(Oregon Health & Science University), Matthew L. Ulrickson, Paul Shaughnessy(CHRISTUS Transplant Institute), Navneet S. Majhail(Sarah Cannon), Divya Koura(University of California San Diego), Marlise R. Luskin(Dana-Farber Cancer Institute), Sumithira Vasu(The Ohio State University), Jacob Boccucci(Augusta University Health), Marc S. Schwartz(University of California San Diego), Luke Mountjoy(Colorado Blood Cancer Institute), Caspian Oliai(APLA Health), Jessica Leonard(Oregon Health & Science University), Evandro D. Bezerra(Cleveland Clinic), Tamer Othman(City Of Hope National Medical Center), Ibrahim Aldoss(City of Hope), Michael R. Grunwald(Levine Cancer Institute), Gregory W. Roloff(University of Chicago), Noam E. Kopmar(University of Washington), Evan C. Chen(Dana-Farber Cancer Institute), Amelia Langston(CancerCare Manitoba), Rasmus T. Hoeg(University of California, Davis), Vamsi Kota(Augusta University), Muthu V. Kumaran(University of Arkansas for Medical Sciences), Veronika Bachanová(University of Minnesota), Talal Hilal(WinnMed), Chenyu Lin(Duke University), Aaron C. Logan(University of California, San Francisco), Ryan D. Cassaday(University of Washington), Minoo Battiwalla(Sarah Cannon), Sean Tracy(Broad Institute), Kaitlyn C. Dykes(University of California San Diego), John A. Mathews(Macquarie University), Anjali S. Advani(Cleveland Clinic), Ran Reshef(Abramson Cancer Center), Yannis K. Valtis(Brigham and Women's Hospital), Timothy E. O’Connor(University of Northern Iowa), Nikeshan Jeyakumar(Stanford Blood Center), Vishal Gupta(University of California, Los Angeles), Amy Zhang, Jae H. Park(Memorial Sloan Kettering Cancer Center), Shahbaz A. Malik(University of Nebraska at Omaha), Katherine C. Sutherland(Stanford University), Melhem Solh(Johns Hopkins Hospital), Katharine Miller(Stanford University), Rawan Faramand(Moffitt Cancer Center)
Cited by 3
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783